Post-Operative Pain – Pipeline Review, H2 2017

Global Markets Direct’s, ‘Post-Operative Pain – Pipeline Review, H2 2017’, provides an overview of the Post-Operative Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain

The report reviews pipeline therapeutics for Post-Operative Pain by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Post-Operative Pain therapeutics and enlists all their major and minor projects

The report assesses Post-Operative Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Post-Operative Pain

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Abide Therapeutics Inc

AcelRx Pharmaceuticals Inc

Adynxx Inc

AngioChem Inc

Aoxing Pharmaceutical Company Inc

Camurus AB

Cara Therapeutics Inc

Center Laboratories Inc

Colby Pharmaceutical Company

Cytogel Pharma LLC

Dompe Farmaceutici SpA

DURECT Corp

Eupraxia Pharmaceuticals Inc

EyeGate Pharmaceuticals Inc

Fujimoto Pharmaceutical Corp

GW Pharmaceuticals Plc

Heron Therapeutics Inc

Immupharma Plc

Innocoll AG

Insys Therapeutics Inc

Lipocure Ltd

Liquidia Technologies Inc

Medtronic Plc

Mundipharma International Ltd

Novartis AG

Orion Oyj

Pacira Pharmaceuticals Inc

PainReform Ltd

PhytoHealth Corp

PixarBio Corp

Proteus SA

Recro Pharma Inc

Relmada Therapeutics Inc

Serina Therapeutics Inc

SteadyMed Therapeutics Inc

Teikoku Pharma USA Inc

The Medicines Company

Trevena Inc

Xigen SA

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Global Markets Direct Report Coverage 7

Post-Operative Pain - Overview 8

Post-Operative Pain - Therapeutics Development 9

Pipeline Overview 9

Pipeline by Companies 10

Pipeline by Universities/Institutes 14

Products under Development by Companies 15

Products under Development by Universities/Institutes 18

Post-Operative Pain - Therapeutics Assessment 19

Assessment by Target 19

Assessment by Mechanism of Action 22

Assessment by Route of Administration 25

Assessment by Molecule Type 27

Post-Operative Pain - Companies Involved in Therapeutics Development 29

Abide Therapeutics Inc 29

AcelRx Pharmaceuticals Inc 29

Adynxx Inc 30

AngioChem Inc 30

Aoxing Pharmaceutical Company Inc 31

Camurus AB 31

Cara Therapeutics Inc 32

Center Laboratories Inc 32

Colby Pharmaceutical Company 33

Cytogel Pharma LLC 33

Dompe Farmaceutici SpA 34

DURECT Corp 34

Eupraxia Pharmaceuticals Inc 35

EyeGate Pharmaceuticals Inc 35

Fujimoto Pharmaceutical Corp 36

GW Pharmaceuticals Plc 36

Heron Therapeutics Inc 37

Immupharma Plc 37

Innocoll AG 38

Insys Therapeutics Inc 38

Lipocure Ltd 39

Liquidia Technologies Inc 39

Medtronic Plc 40

Mundipharma International Ltd 40

Novartis AG 41

Orion Oyj 41

Pacira Pharmaceuticals Inc 42

PainReform Ltd 42

PhytoHealth Corp 43

PixarBio Corp 43

Proteus SA 44

Recro Pharma Inc 44

Relmada Therapeutics Inc 45

Serina Therapeutics Inc 45

SteadyMed Therapeutics Inc 46

Teikoku Pharma USA Inc 46

The Medicines Company 47

Trevena Inc 47

Xigen SA 48

Post-Operative Pain - Drug Profiles 49

(bupivacaine hydrochloride + meloxicam) ER - Drug Profile 49

(buprenorphine hydrochloride + granisetron hydrochloride) ER - Drug Profile 52

A-100 - Drug Profile 53

ABD-1970 - Drug Profile 54

ANG-2002 - Drug Profile 55

ARX-04 - Drug Profile 56

AYX-1 - Drug Profile 64

brimapitide - Drug Profile 67

bupivacaine hydrochloride - Drug Profile 71

bupivacaine hydrochloride - Drug Profile 72

bupivacaine hydrochloride - Drug Profile 73

bupivacaine hydrochloride - Drug Profile 74

bupivacaine hydrochloride SR - Drug Profile 77

bupivacaine hydrochloride SR - Drug Profile 82

buprenorphine hydrochloride - Drug Profile 83

CAM-2048 - Drug Profile 84

carbamazepine - Drug Profile 85

CPC-111 - Drug Profile 86

CPC-123 - Drug Profile 87

CT-044 - Drug Profile 88

Cyt-1010 - Drug Profile 89

dexamethasone acetate - Drug Profile 91

dexmedetomidine hydrochloride - Drug Profile 97

DF-2755A - Drug Profile 98

difelikefalin - Drug Profile 99

Drug to Agonize MOR1 for Pain - Drug Profile 109

ECP-1014 - Drug Profile 110

fadolmidine hydrochloride - Drug Profile 112

fentanyl - Drug Profile 113

gonyautoxin - Drug Profile 114

HTX-009 - Drug Profile 115

HYLP-002 - Drug Profile 116

IPP-102199 - Drug Profile 117

ketorolac tromethamine - Drug Profile 118

lacosamide - Drug Profile 119

levorphanol tartrate ER - Drug Profile 120

MDT-10013 - Drug Profile 122

meloxicam - Drug Profile 123

meloxicam ER - Drug Profile 128

MR-309 - Drug Profile 129

nabiximols - Drug Profile 131

nalbuphine hydrochloride - Drug Profile 138

neosaxitoxin - Drug Profile 139

oliceridine - Drug Profile 141

PMZ-2010 - Drug Profile 148

RBM-004 - Drug Profile 150

ropivacaine - Drug Profile 151

ropivacaine ER - Drug Profile 152

SAF-312 - Drug Profile 153

SER-226 - Drug Profile 154

Small Molecule for Post-Operative Pain - Drug Profile 155

Small Molecules to Inhibit COX for Postoperative Acute Pain - Drug Profile 156

sufentanil citrate - Drug Profile 157

tilidine hydrochloride - Drug Profile 165

tramadol hydrochloride - Drug Profile 166

URB-937 - Drug Profile 167

VVZ-149 - Drug Profile 168

XEN-105 - Drug Profile 170

Post-Operative Pain - Dormant Projects 171

Post-Operative Pain - Discontinued Products 174

Post-Operative Pain - Product Development Milestones 175

Featured News & Press Releases 175

Appendix 186

Methodology 186

Coverage 186

Secondary Research 186

Primary Research 186

Expert Panel Validation 186

Contact Us 186

Disclaimer 187

List of Tables

List of Tables

Number of Products under Development for Post-Operative Pain, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Products under Development by Companies, H2 2017

Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Products under Development by Universities/Institutes, H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Post-Operative Pain – Pipeline by Abide Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by AcelRx Pharmaceuticals Inc, H2 2017

Post-Operative Pain – Pipeline by Adynxx Inc, H2 2017

Post-Operative Pain – Pipeline by AngioChem Inc, H2 2017

Post-Operative Pain – Pipeline by Aoxing Pharmaceutical Company Inc, H2 2017

Post-Operative Pain – Pipeline by Camurus AB, H2 2017

Post-Operative Pain – Pipeline by Cara Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by Center Laboratories Inc, H2 2017

Post-Operative Pain – Pipeline by Colby Pharmaceutical Company, H2 2017

Post-Operative Pain – Pipeline by Cytogel Pharma LLC, H2 2017

Post-Operative Pain – Pipeline by Dompe Farmaceutici SpA, H2 2017

Post-Operative Pain – Pipeline by DURECT Corp, H2 2017

Post-Operative Pain – Pipeline by Eupraxia Pharmaceuticals Inc, H2 2017

Post-Operative Pain – Pipeline by EyeGate Pharmaceuticals Inc, H2 2017

Post-Operative Pain – Pipeline by Fujimoto Pharmaceutical Corp, H2 2017

Post-Operative Pain – Pipeline by GW Pharmaceuticals Plc, H2 2017

Post-Operative Pain – Pipeline by Heron Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by Immupharma Plc, H2 2017

Post-Operative Pain – Pipeline by Innocoll AG, H2 2017

Post-Operative Pain – Pipeline by Insys Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by Lipocure Ltd, H2 2017

Post-Operative Pain – Pipeline by Liquidia Technologies Inc, H2 2017

Post-Operative Pain – Pipeline by Medtronic Plc, H2 2017

Post-Operative Pain – Pipeline by Mundipharma International Ltd, H2 2017

Post-Operative Pain – Pipeline by Novartis AG, H2 2017

Post-Operative Pain – Pipeline by Orion Oyj, H2 2017

Post-Operative Pain – Pipeline by Pacira Pharmaceuticals Inc, H2 2017

Post-Operative Pain – Pipeline by PainReform Ltd, H2 2017

Post-Operative Pain – Pipeline by PhytoHealth Corp, H2 2017

Post-Operative Pain – Pipeline by PixarBio Corp, H2 2017

Post-Operative Pain – Pipeline by Proteus SA, H2 2017

Post-Operative Pain – Pipeline by Recro Pharma Inc, H2 2017

Post-Operative Pain – Pipeline by Relmada Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by Serina Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by SteadyMed Therapeutics Inc, H2 2017

Post-Operative Pain – Pipeline by Teikoku Pharma USA Inc, H2 2017

Post-Operative Pain – Pipeline by The Medicines Company, H2 2017

Post-Operative Pain – Pipeline by Trevena Inc, H2 2017

Post-Operative Pain – Pipeline by Xigen SA, H2 2017

Post-Operative Pain – Dormant Projects, H2 2017

Post-Operative Pain – Dormant Projects, H2 2017 (Contd..1), H2 2017

Post-Operative Pain – Dormant Projects, H2 2017 (Contd..2), H2 2017

Post-Operative Pain – Discontinued Products, H2 2017

List of Figures

List of Figures

Number of Products under Development for Post-Operative Pain, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Top 10 Routes of Administration, H2 2017

Number of Products by Stage and Top 10 Routes of Administration, H2 2017

Number of Products by Molecule Types, H2 2017

Number of Products by Stage and Molecule Types, H2 2017

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports